We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+7.77%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.38B
AUM Growth
+$750M
(+28%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
29.86%
Top 10 Holdings %
Top 10 Hldgs %
27.81%
Holding
544
New
135
Increased
136
Reduced
128
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$389M |
| 2 |
Microsoft
MSFT
|
+$95.1M |
| 3 |
Apple
AAPL
|
+$51.5M |
| 4 |
Masco
MAS
|
+$45.7M |
| 5 |
McDonald's
MCD
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
F5
FFIV
|
+$49M |
| 2 |
MSCI
MSCI
|
+$30.2M |
| 3 |
Pilgrim's Pride
PPC
|
+$29.4M |
| 4 |
Amdocs
DOX
|
+$22.9M |
| 5 |
ANSS
Ansys
ANSS
|
+$21.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.08% |
| 2 | Healthcare | 18.13% |
| 3 | Technology | 17.51% |
| 4 | Industrials | 12.07% |
| 5 | Consumer Staples | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AFFX
151
DELISTED
Affymetrix Inc
AFFX
| $1.65M | 0.05% |
163,010
-20,920
| -11% | -$193K |
|
|
DYAX
152
DELISTED
DYAX CORPORATION
DYAX
| $1.64M | 0.05% |
43,480
-6,700
| -13% | -$215K |
|
153
The Greenbrier Companies
GBX
$1.43B
| $1.63M | 0.05% |
50,027
-8,140
| -14% | -$279K |
|
154
Cytokinetics
CYTK
$10.5B
| $1.63M | 0.05% |
155,670
-21,340
| -12% | -$209K |
|
155
Qualcomm
QCOM
$170B
| $1.62M | 0.05% |
32,414
+32,369
| +71,931% | +$1.73M |
|
156
Procter & Gamble
PG
$340B
| $1.58M | 0.05% |
19,958
+19,921
| +53,841% | +$1.52M |
|
|
XCRA
157
DELISTED
Xcerra Corporation
XCRA
| $1.57M | 0.05% |
260,060
-41,220
| -14% | -$270K |
|
158
SEI Investments
SEIC
$12.6B
| $1.49M | 0.04% |
+28,490
| New | +$1.48M |
|
|
OUTR
159
DELISTED
OUTERWALL INC
OUTR
| $1.46M | 0.04% |
39,993
-6,350
| -14% | -$354K |
|
|
ACHN
160
DELISTED
Achillion Pharmaceuticals
ACHN
| $1.32M | 0.04% |
122,500
-19,010
| -13% | -$173K |
|
|
SHOR
161
DELISTED
ShoreTel, Inc.
SHOR
| $1.27M | 0.04% |
+143,790
| New | +$1.34M |
|
162
United Parcel Service
UPS
$89.1B
| $1.21M | 0.04% |
+12,567
| New | +$1.28M |
|
163
New York Times
NYT
$10.5B
| $1.18M | 0.03% |
+87,860
| New | +$1.17M |
|
|
WW
164
DELISTED
WW International
WW
| $1.16M | 0.03% |
50,890
+44,020
| +641% | +$830K |
|
165
Autodesk
ADSK
$54.1B
| $1.14M | 0.03% |
+18,738
| New | +$1.09M |
|
166
Citi Trends
CTRN
$618M
| $1.14M | 0.03% |
53,480
-6,460
| -11% | -$150K |
|
|
KYNB
167
Kyntra Bio
KYNB
$28.2M
| $1.1M | 0.03% |
1,446
-247
| -15% | -$164K |
|
|
VAR
168
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.08M | 0.03% |
+15,194
| New | +$1.05M |
|
169
Novartis
NVS
$298B
| $1.07M | 0.03% |
+13,884
| New | +$1.1M |
|
170
Yum! Brands
YUM
$39.7B
| $1.06M | 0.03% |
+20,118
| New | +$1.05M |
|
171
Amgen
AMGN
$226B
| $1.05M | 0.03% |
6,456
+6,446
| +64,460% | +$1.01M |
|
172
Neurocrine Biosciences
NBIX
$16.8B
| $1.01M | 0.03% |
+17,870
| New | +$908K |
|
|
PGNX
173
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $935K | 0.03% |
152,470
-3,590
| -2% | -$23.5K |
|
|
NTUS
174
DELISTED
Natus Medical Inc
NTUS
| $917K | 0.03% |
19,080
-3,000
| -14% | -$139K |
|
175
Exelixis
EXEL
$13.1B
| $911K | 0.03% |
161,460
-25,410
| -14% | -$142K |
|
Similar funds
M
GWM
QT
SCM
TW
KFA
SG
FFA
Smith Group Asset Management's Q4 2015 Portfolio in Review
As of Q4 2015, Smith Group Asset Management held 544 positions worth $3.38B, up 28% from $2.63B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Smith Group Asset Management deployed $1.01B of net new capital in Q4 2015, opening 135 new positions and adding to 136 existing holdings. Its largest new stake was Masco: 1,605,910 shares worth $45.4M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Lockheed Martin, an estimated $15.9M trimmed.
- Smith Group Asset Management's largest Q4 2015 buy was Masco: 1,605,910 shares worth $45.4M.
- Smith Group Asset Management added most to Allergan plc in Q4 2015, an estimated $389M increase.
- Smith Group Asset Management's biggest Q4 2015 reduction was Lockheed Martin, cutting an estimated $15.9M.
- Smith Group Asset Management fully exited F5 in Q4 2015, selling an estimated $49M.
- Smith Group Asset Management's ten largest holdings make up 28% of its $3.38B portfolio in Q4 2015.
- Smith Group Asset Management opened 135 new positions and closed 73 in Q4 2015.
- Smith Group Asset Management's portfolio value rose 28% quarter-over-quarter to $3.38B.
Based on Smith Group Asset Management's 13F filing for Q4 2015, filed 3 Feb 2016.